Evolution of hepatitis B virus liver disease after hepatic replacement. Practical and theoretical considerations.
about
Prevention and Treatment of Recurrent Hepatitis B after Liver TransplantationKASL clinical practice guidelines: management of chronic hepatitis BMolecular Mechanisms to Control Post-Transplantation Hepatitis B RecurrenceFibrosing cholestatic hepatitis C in post-transplant adult recipients of liver transplantationRecurrent hepatitis C in liver allografts: prospective assessment of diagnostic accuracy, identification of pitfalls, and observations about pathogenesis.Recurrence of hepatitis B and delta hepatitis after orthotopic liver transplantationIncidence and severity of acute allograft rejection in liver transplant recipients treated with alfa interferonStructural integrity and identification of causes of liver allograft dysfunction occurring more than 5 years after transplantation.KASL Clinical Practice Guidelines: Management of chronic hepatitis B.Fibrosing cholestatic hepatitis: clinicopathologic spectrum, diagnosis and pathogenesis.Strategies for the prevention of recurrent hepatitis B virus infection after liver transplantation.Interferon therapy of hepatitis following liver transplantation under FK 506 or cyclosporine.Infection in the bone marrow transplant recipient and role of the microbiology laboratory in clinical transplantation.Posttransplant B, non-A non-B, and cytomegalovirus hepatitis increase the risk of developing chronic rejection after liver transplantation.Liver transplantation--challenges for the future.Hepatitis B virus infection and liver transplantation.Post-transplant recurrent hepatitis B viral liver disease. Viral-burden, steatoviral, and fibroviral hepatitis B.Hepatic Failure Due to Cholestatic Hepatitis C in an Immunosuppressed Patient Treated With Elbasvir and Grazeprevir.
P2860
Q26751777-22ECCB18-68BE-4F59-A4EC-42CDBF829168Q26752475-E7C186F7-4FB9-4A79-923D-6D2C7CA6EEFBQ26799246-7DCA8612-AB72-4BE8-8A4E-F6146895AC1FQ28076406-5F334EBF-0F49-49C5-A029-99B6E0F43E87Q34280934-6E4C3E54-2D40-4BAA-AF7A-1882A7FC8F45Q34396583-B72221BE-88E1-495C-A278-B6B9DC835474Q34423385-F6DF2379-E6B0-4824-A7C5-F150A7932AA7Q34985253-7E0A7F31-FBFC-477A-8288-E7A7863B6206Q36153966-CF54799D-4207-4C14-908C-C9C196647E83Q37267233-D7D2E650-2393-4255-A143-D1968A2B17FCQ39372160-592EC635-7E79-4DC4-948B-1943FE945584Q39449985-1B5FC00E-478B-4897-99EA-3736B587E98AQ39820778-EC9C7728-79C7-4897-BB0C-78FE872ED358Q41841314-5D27E0D9-EFAB-4BE4-8D42-9F7CD79E5E2CQ42543289-2D36F96A-4C44-48E6-AC21-1CDF57D3486BQ42581069-6E237C05-A179-4581-AEDA-360A6F1BFB17Q42755608-E2103CBF-6553-49A0-B0C3-26C0B21ED7B7Q49385150-9375807B-2F7C-4E26-8E1D-52B43B4C4FA1
P2860
Evolution of hepatitis B virus liver disease after hepatic replacement. Practical and theoretical considerations.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
1990年论文
@zh
1990年论文
@zh-cn
name
Evolution of hepatitis B virus ...... nd theoretical considerations.
@ast
Evolution of hepatitis B virus ...... nd theoretical considerations.
@en
type
label
Evolution of hepatitis B virus ...... nd theoretical considerations.
@ast
Evolution of hepatitis B virus ...... nd theoretical considerations.
@en
prefLabel
Evolution of hepatitis B virus ...... nd theoretical considerations.
@ast
Evolution of hepatitis B virus ...... nd theoretical considerations.
@en
P2093
P2860
P50
P1476
Evolution of hepatitis B virus ...... nd theoretical considerations.
@en
P2093
P2860
P304
P407
P577
1990-09-01T00:00:00Z